Precision NanoSystems is a global leader in the field of genomic medicine, providing advanced technologies, solutions, and services for the development of lipid nanoparticle delivery systems. These systems play a crucial role in the development of mRNA vaccines and therapeutics. Precision NanoSystems offers a wide range of products and services, including the NxGen Technology Instruments such as NanoAssemblr® Spark™, Ignite™, Ignite+™, Blaze™, GMP System, and Commercial Formulation System.

These instruments enable efficient and robust manufacturing processes for lipid nanoparticles. Additionally, Precision NanoSystems provides a portfolio of Lipid Nanoparticle Reagents, GenVoy-ILM T Cell Kits, and BioPharma Services for proof-of-concept studies and lead candidate development. With a focus on applications in oncology, rare diseases, infectious diseases, and drug payloads including mRNA, siRNA, plasmids, small molecules, proteins, and peptides, Precision NanoSystems is dedicated to accelerating the development of transformative genomic medicines.

They also offer training courses, educational resources, and partner with other organizations in the field